NO305210B1 - 17-deoksy-korticosteroid-21-[0]-karboksylsyreester og legemiddel inneholdende forbindelsen - Google Patents

17-deoksy-korticosteroid-21-[0]-karboksylsyreester og legemiddel inneholdende forbindelsen

Info

Publication number: NO305210B1
Authority: NO; Norway
Prior art keywords: deoxy; carboxylic acid; opt; corticosteroid; compound
Prior art date: 1994-09-20

Application number

NO953695A

Other languages

English (en)

Norwegian (no)

Other versions

NO953695D0 (no

NO953695L (no

Inventor

Ulrich Stache

Hans Georg Alpermann

Manfred Bohn

Original Assignee

Hoechst Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-20

Filing date

1995-09-19

Publication date

1999-04-19

1995-09-19 Application filed by Hoechst Ag filed Critical Hoechst Ag

1995-09-19 Publication of NO953695D0 publication Critical patent/NO953695D0/no

1996-03-21 Publication of NO953695L publication Critical patent/NO953695L/no

1999-04-19 Publication of NO305210B1 publication Critical patent/NO305210B1/no

Links

125000003262 carboxylic acid ester group Chemical class [H]C([H])([*:2])OC(=O)C([H])([H])[*:1] 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000002947 alkylene group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000004122 cyclic group Chemical group 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO953695A 1994-09-20 1995-09-19 17-deoksy-korticosteroid-21-[0]-karboksylsyreester og legemiddel inneholdende forbindelsen NO305210B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4433374A DE4433374A1 (de)	1994-09-20	1994-09-20	17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (3)

Publication Number	Publication Date
NO953695D0 NO953695D0 (no)	1995-09-19
NO953695L NO953695L (no)	1996-03-21
NO305210B1 true NO305210B1 (no)	1999-04-19

Family

ID=6528610

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO953695A NO305210B1 (no)	1994-09-20	1995-09-19	17-deoksy-korticosteroid-21-[0]-karboksylsyreester og legemiddel inneholdende forbindelsen

Country Status (24)

Country	Link
US (1)	US5824670A (pt)
EP (1)	EP0708111B1 (pt)
JP (1)	JP3902255B2 (pt)
KR (1)	KR100406627B1 (pt)
CN (1)	CN1056151C (pt)
AT (1)	ATE188480T1 (pt)
AU (1)	AU695710B2 (pt)
CA (1)	CA2158610C (pt)
CZ (1)	CZ288297B6 (pt)
DE (2)	DE4433374A1 (pt)
DK (1)	DK0708111T3 (pt)
ES (1)	ES2140596T3 (pt)
FI (1)	FI114708B (pt)
GR (1)	GR3032688T3 (pt)
HU (1)	HU217438B (pt)
IL (1)	IL115331A (pt)
NO (1)	NO305210B1 (pt)
NZ (1)	NZ280038A (pt)
PL (1)	PL186071B1 (pt)
PT (1)	PT708111E (pt)
RU (1)	RU2161624C2 (pt)
SI (1)	SI9500295B (pt)
TW (1)	TW424094B (pt)
ZA (1)	ZA957877B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2180216C2 (ru) *	2000-03-13	2002-03-10	Открытое акционерное общество "Биосинтез"	Препарат, обладающий антимикробным и регенерирующим действием
WO2012011106A1 (en) *	2010-07-20	2012-01-26	Taro Pharmaceutical Industries Ltd.	Process for the preparation of 17-desoxy-corticosteroids
US12209988B2 (en)	2019-05-24	2025-01-28	Electronics And Telecommunications Research Institute	Sensor and method of manufacturing the same

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2755292A (en) *	1952-01-21	1956-07-17	Organon Labor Ltd	Phenyl propionate of testosterone
US2783226A (en) *	1955-02-03	1957-02-26	Schering Corp	Esters of cortical hormones
ES229413A1 (es) *	1956-06-22	1956-11-01	Francisco Vismara S P A	UN PROCEDIMIENTO PARA LA PREPARACIoN DE COMPUESTOS ESTEROIDALES QUE CONTENGAN UN GRUPO CEToLICO EN LA CADENA LATERAL
DE1131668B (de) *	1959-07-16	1962-06-20	Leo Ab	Verfahren zur Herstellung von Estern von Corticosteroid-Hormonen
CH495969A (de) *	1965-11-09	1970-09-15	Schering Ag	Verfahren zur Herstellung neuer 21-Ester von 16a-Methyl-21-hydroxy- 1,4-steroiden
DE2047105C3 (de) *	1970-09-18	1979-02-15	Schering Ag, 1000 Berlin Und 4619 Bergkamen	17-Chlorsteroide und Verfahren zu ihrer Herstellung
US3956349A (en) *	1975-02-18	1976-05-11	Syntex (U.S.A.) Inc.	Process for preparing 3-enol ethers of 11β-hydroxy-Δ4 -pregnene-3-ones and derivatives thereof
FR2342738A1 (fr) *	1976-03-02	1977-09-30	Roussel Uclaf	Nouveaux derives halogenes de la serie du 16a-methyl pregnane
DE2617655C2 (de) *	1976-04-21	1984-11-08	F. Hoffmann-La Roche & Co Ag, Basel	Kortikoide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE2645104C2 (de) *	1976-10-04	1986-04-24	Schering AG, 1000 Berlin und 4709 Bergkamen	11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
FR2381065A2 (fr) *	1977-02-22	1978-09-15	Roussel Uclaf	Nouveaux derives halogenes de la serie du 16 a-methyl pregnane
US4086254A (en) *	1977-04-13	1978-04-25	The Upjohn Company	Photocleavable steroids
LU77457A1 (pt) *	1977-05-31	1979-01-19
US4377573A (en) *	1978-01-06	1983-03-22	Leveen Harry H	Method of control of gastrointestinal bleeding
DE2817988A1 (de) *	1978-04-25	1979-11-08	Hoechst Ag	Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
DE2920726A1 (de) *	1979-05-18	1980-11-27	Schering Ag	Neue kortikoide, ihre herstellung und verwendung
EP0039369B1 (en) *	1980-05-02	1983-06-15	Schering Corporation	Beclomethasone ester solvates, process for their preparation, and preparation of a formulation
CY1359A (en) *	1981-02-02	1987-08-07	Schering Corp	Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
SE8303031D0 (sv) *	1983-05-30	1983-05-30	Leo Ab	Improved steroid esters preparation
US4910191A (en) *	1988-06-28	1990-03-20	Merrell Dow Pharmaceuticals Inc.	19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
US4920114A (en) *	1988-06-28	1990-04-24	Merrell Dow Pharmaceuticals Inc.	19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as 19-hydroxylase inhibitors
CA2038985C (en) *	1990-04-02	2002-10-15	Joseph P. Burkhart	Haloethyl-substituted steroidal enzyme inhibitors

1994
- 1994-09-20 DE DE4433374A patent/DE4433374A1/de not_active Withdrawn
1995
- 1995-09-08 TW TW084109384A patent/TW424094B/zh not_active IP Right Cessation
- 1995-09-15 ES ES95114511T patent/ES2140596T3/es not_active Expired - Lifetime
- 1995-09-15 DK DK95114511T patent/DK0708111T3/da active
- 1995-09-15 EP EP95114511A patent/EP0708111B1/de not_active Expired - Lifetime
- 1995-09-15 PT PT95114511T patent/PT708111E/pt unknown
- 1995-09-15 DE DE59507565T patent/DE59507565D1/de not_active Expired - Lifetime
- 1995-09-15 AT AT95114511T patent/ATE188480T1/de active
- 1995-09-18 IL IL11533195A patent/IL115331A/en not_active IP Right Cessation
- 1995-09-18 AU AU31728/95A patent/AU695710B2/en not_active Ceased
- 1995-09-18 FI FI954394A patent/FI114708B/fi not_active IP Right Cessation
- 1995-09-18 US US08/529,668 patent/US5824670A/en not_active Expired - Lifetime
- 1995-09-18 NZ NZ280038A patent/NZ280038A/en not_active IP Right Cessation
- 1995-09-18 CZ CZ19952425A patent/CZ288297B6/cs not_active IP Right Cessation
- 1995-09-18 CN CN95116294A patent/CN1056151C/zh not_active Expired - Fee Related
- 1995-09-19 NO NO953695A patent/NO305210B1/no not_active IP Right Cessation
- 1995-09-19 CA CA002158610A patent/CA2158610C/en not_active Expired - Fee Related
- 1995-09-19 RU RU95116371/04A patent/RU2161624C2/ru not_active IP Right Cessation
- 1995-09-19 ZA ZA957877A patent/ZA957877B/xx unknown
- 1995-09-19 HU HU9502735A patent/HU217438B/hu not_active IP Right Cessation
- 1995-09-19 JP JP23939895A patent/JP3902255B2/ja not_active Expired - Fee Related
- 1995-09-19 PL PL95310544A patent/PL186071B1/pl not_active IP Right Cessation
- 1995-09-20 KR KR1019950030850A patent/KR100406627B1/ko not_active Expired - Fee Related
- 1995-09-20 SI SI9500295A patent/SI9500295B/sl unknown
2000
- 2000-02-18 GR GR20000400386T patent/GR3032688T3/el unknown

Also Published As

Publication number	Publication date
SI9500295B (en)	2001-12-31
IL115331A0 (en)	1995-12-31
HUT72969A (en)	1996-06-28
JP3902255B2 (ja)	2007-04-04
FI954394L (fi)	1996-03-21
US5824670A (en)	1998-10-20
SI9500295A (en)	1996-04-30
AU695710B2 (en)	1998-08-20
PL186071B1 (pl)	2003-10-31
JPH0899992A (ja)	1996-04-16
GR3032688T3 (en)	2000-06-30
TW424094B (en)	2001-03-01
FI954394A0 (fi)	1995-09-18
IL115331A (en)	2002-07-25
CN1056151C (zh)	2000-09-06
KR960010681A (ko)	1996-04-20
NO953695D0 (no)	1995-09-19
NO953695L (no)	1996-03-21
KR100406627B1 (ko)	2004-02-19
AU3172895A (en)	1996-04-04
DE4433374A1 (de)	1996-03-21
CN1124250A (zh)	1996-06-12
NZ280038A (en)	1997-03-24
CA2158610A1 (en)	1996-03-21
ES2140596T3 (es)	2000-03-01
HU9502735D0 (en)	1995-11-28
FI114708B (fi)	2004-12-15
CA2158610C (en)	2007-07-17
PT708111E (pt)	2000-04-28
PL310544A1 (en)	1996-04-01
DK0708111T3 (da)	2000-06-13
CZ242595A3 (en)	1996-04-17
CZ288297B6 (en)	2001-05-16
ZA957877B (en)	1996-04-03
EP0708111A1 (de)	1996-04-24
EP0708111B1 (de)	2000-01-05
ATE188480T1 (de)	2000-01-15
HU217438B (hu)	2000-01-28
RU2161624C2 (ru)	2001-01-10
DE59507565D1 (de)	2000-02-10

Legal Events

Date	Code	Title	Description
2015-04-27	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
DK205789D0 (da)	1989-04-27	Optisk aktive pyridoncarboxylsyrederivater og laegemidler indeholdende disse
NO933376D0 (no)	1993-09-22	Morfinan-derivater og medisinsk anvendelse derav
DK0605193T3 (da)	2003-03-31	Anvendelse af benzothiophener til behandling af hypercholesterolæmi
DE68925155D1 (de)	1996-02-01	Verwendung von Halogenkohlenwasserstofflösungsmittel als Reinigungsmittel
WO1991000082A1 (en)	1991-01-10	Antimicrobial polymeric bisbiguanides
ATE191142T1 (de)	2000-04-15	Verwendung von phenalkylaminen zur herstellung von cholesterinsenkenden arzneimitteln
NO953695D0 (no)	1995-09-19	17-deoksy-korticosteroid-21- 0 -karboksylsyreester, fremgangsmåte for fremstilling derav og legemiddel inneholdende forbindelsen
GR3029428T3 (en)	1999-05-28	Novel bisoxadiazolidine derivative
DE69411616D1 (de)	1998-08-20	Triazolopyridazin-Derivate, ihre Herstellung und Verwendung
DE69126758D1 (de)	1997-08-14	Benzamid-Derivate
ATE142620T1 (de)	1996-09-15	1-alkyl-2-acyl-1,2-disulfonylhydrazine mit antineoplastischer aktivität
EP0461574A3 (en)	1992-03-25	Medicines containing 3,7-diazabicyclo(3,3,1)nonanes
DE69127935D1 (de)	1997-11-20	Antibiotikum Balmimycin, dessen Verfahren zur Herstellung und dessen Verwendung als Arznei
EP0356765A3 (en)	1991-08-07	Carboxylic acid derivatives, their production and use
DE3889083D1 (de)	1994-05-19	Pyrrolophthalazine.
ATE158587T1 (de)	1997-10-15	Galactosamin-substituierte poly-omega- substituierte l-glutaminsäure und/oder - asparaginsäure
DE68910736D1 (de)	1993-12-23	Fungizide heterozyklische Stickstoffverbindungen.
FR2655042B1 (fr)	1994-01-21	Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE68906930D1 (de)	1993-07-15	Herstellung von optisch aktiven n-substituierten alaninherbiciden.
DE59105961D1 (de)	1995-08-17	2,13-disubstituierte ergoline, deren herstellung und verwendung in arzneimitteln.